Search
for
Sort by
Research 361–390 of 1000+
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Mechanisms regulating skin immunity and inflammation
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Immunopathogenesis of Primary Cicatricial Alopecia
- Interrelation of immunity and tissue repair or regeneration
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- An essential role for <i>Rxrα</i> in the development of Th2 responses
- Immune therapies for alopecia areata: evidence and new perspectives
- Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- CAQ Corner: Basic concepts of transplant immunology
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata: Treatment of Today and Tomorrow
- Stem cell-based therapies for alopecia areata: a narrative review
- Stem-cell therapy in dermatology – Challenges and opportunities
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata
- Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence